Spun out of the Bonde Artificial Heart Lab at Yale University, Bonde Innovations is developing an innovative, catheter implanted circulatory assist device, CoRISMA, to treat Class 3 and Class 4 heart failure patients. With $2M+ grant funding, CoRISMA has been designed to improve patients' quality of life and reduce cost and invasiveness associated with the current therapies. All the components of the devices have been prototyped and tested at Yale.
Discover the best career opportunities with the best company cultures for you.
Connect your business to thousands of engaged professionals in your city and beyond.